Disrupting the pharma industry - Introducing the world's first AI-designed drug


In January 2020, Exscientia was ready to announce a world-first: their precision-engineered drug, designed using artificial intelligence, was about to enter clinical trials. In less than three weeks we built a compelling narrative and earned strategy, which smashed KPIs and resulted in more 120 articles being published in top-tier publications such as the Financial Times, BBC, Bloomberg and Forbes.

Off the back of this success, Exscientia is now seen as an undisputed leader within AI drug discovery and is the most-searched AI drug discovery company in the world seeing a near 100% increase in total mentions in 2020 vs 2019.